<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two patients with <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) who developed characteristic features of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (BD) during alpha-interferon (IFN-alpha) treatment and another patient who had a diagnosis of BD preceding <z:mp ids='MP_0005481'>CML</z:mp> are presented </plain></SENT>
<SENT sid="1" pm="."><plain>In the first two patients, features of BD appeared 6 months after the initiation of IFN-alpha treatment: they included <z:e sem="disease" ids="C0554021" disease_type="Disease or Syndrome" abbrv="">recurrent oral aphthae</z:e>, <z:e sem="disease" ids="C0151281" disease_type="Disease or Syndrome" abbrv="">genital ulceration</z:e>, <z:hpo ids='HP_0001369'>arthritis</z:hpo>, <z:mp ids='MP_0000376'>folliculitis</z:mp>, and a positive skin <z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> test </plain></SENT>
<SENT sid="2" pm="."><plain>The third patient, however, had a diagnosis of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease 4 years before diagnosis of Philadelphia-positive <z:mp ids='MP_0005481'>CML</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>We prospectively examined the skin <z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> reaction in a group of patients with <z:mp ids='MP_0005481'>CML</z:mp>, <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, and hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> both before and after IFN-alpha treatment and found two additional patients with <z:mp ids='MP_0005481'>CML</z:mp> who developed a positive skin <z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> test following IFN-alpha treatment </plain></SENT>
</text></document>